Disease Models & MechanismsPathologyPeer-reviewed journal article
Modeling Immunoglobulin light chain amyloidosis in Caenorhabditis elegans
Margherita RomeoiD, Maria Monica BarzagoiD, Alessandro CorbelliiD, Silvia MaglioniiD, Natascia VenturaiD, Carmina NataleiD, Andrea ConziD, Mario SalmonaiD, Giovanni O. PalladiniiD, Mario NuvoloneiD, Fabio FiordalisoiD, Giampaolo MerliniiD, Luisa DiomedeiD
Abstract
Cardiomyopathy determines the prognosis of patients with immunoglobulin light chain (AL) amyloidosis, a rare systemic disease caused by the misfolding and deposition of monoclonal light chains (LCs). The reasons underlining their cardiac tropism remain unknown, and an animal model recapitulating the main pathological features of AL amyloidosis is instrumental. Taking advantage of the similarities between the vertebrate heart and C. elegans pharynx, we developed a new transgenic nematode expressing a human amyloidogenic {lambda} LC whose sequence was deduced from a patient suffering from AL amyloidosis with cardiac involvement (MNH). Strains expressing a non-amyloidogenic LC (MNM) or the empty vector only (MNV) were generated as controls. At variance with controls, LCs expressed in the body-wall muscle of MNH worms formed native soluble dimeric assemblies, which were secreted and reached different organs, including the pharynx. Noteworthy, MNH worms exerted a pharyngeal impairment resembling cardiac functional impairment occurring in patients with AL, accompanied by increased radical oxygen species production and tissue ultrastructural damage. This new animal model can allow the elucidation of the mechanisms underlying the cardiac-specific tropism occurring in AL amyloidosis, providing innovative insights into the pathophysiology.
- organism: C. elegans
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 2
- FWCI
- 1.78
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A mouse model of cardiac AL amyloidosis unveils mechanisms of tissue accumulation and toxicity of amyloid fibrils
Gemma Martinez-Rivas, Maria Victoria Ayala, … Christophe Sirac·Nature CommunicationsPeer-reviewed·Mar 27, 2025
- Exploring light chain cardiotoxicity in AL amyloidosis: Impact on hiPSC-derived Cardiomyocyte Activity
Serena Calamaio, Anthony Frosio, … Ilaria Rivolta·AmyloidPeer-reviewed·Jun 19, 2026
- Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation
L. Broggini, M. Barzago, … S. Ricagno·bioRxiv·Aug 28, 2023
- Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain (AL) amyloidosis patient
P. Swuec, F. Lavatelli, … M. Bolognesi·bioRxiv·Oct 17, 2018
- Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition
C. V. Edwards, G. M. Ferri, … G. J. Murphy·bioRxiv·Mar 14, 2024
- Mathematical Modeling of Late-Stage LC Aggregation and Cardiac Injury Following Establishment of a Pathogenic Plasma-Cell Clone
Andrey V. Kuznetsov·bioRxiv·Oct 30, 2025